Versant Vantage II, L.P. - Insider Trading & Ownership
-
Entity
-
Company
-
Location
-
One Sansome Street, Suite 1650, San Francisco, CA
-
Summary
-
The estimated value of insider holdings of Versant Vantage II, L.P. is at least $10.1M dollars as of May 3, 2022. Versant Vantage II, L.P. is the 10%+ Owner of Tempest Therapeutics, Inc. and owns shares of Tempest Therapeutics, Inc. (TPST) stock worth about $10.1M.